|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 11/26/14 S1 Biopharma, Inc. 8-A12B/A 1:24K Merrill Corp-MD/FA |
Document/Exhibit Description Pages Size 1: 8-A12B/A Amendment to 8-A12B HTML 18K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A/A
(Amendment No. 1)
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
S1 BIOPHARMA, INC.
(Exact name of registrant as specified in its charter)
|
Delaware |
|
27-3629427 |
|
(State of incorporation or organization) |
|
(IRS Employer Identification No.) |
|
|
|
|
|
7 World Trade Center 250 Greenwich St., 46th Floor New York City, NY |
|
10007 |
|
(Address of principal executive offices) |
|
(Zip Code) |
Securities to be registered pursuant to Section 12(b) of the Act:
|
Title of each class |
|
Name of each exchange on which |
|
|
|
|
|
Units, each consisting of one share of common stock, $0.0001 par value per share, one Series A warrant to purchase one share of common stock, and one Series B warrant to purchase one share of common stock |
|
The NASDAQ Stock Market LLC |
|
Common Stock, $0.0001 par value per share |
|
The NASDAQ Stock Market LLC |
|
Series A warrants to purchase common stock |
|
The NASDAQ Stock Market LLC |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. x
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. o
Securities Act registration statement file number to which this form relates: 333-199111
Securities to be registered pursuant to Section 12(g) of the Act: None.
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Item 1. Description of Securities to be Registered.
A description of securities of S1 Biopharma, Inc., a Delaware corporation (the “Registrant”), to be registered hereunder, is contained in the section entitled “Description of Capital Stock” in the prospectus that constitutes part of the Registrant’s Registration Statement on Form S-1 (File No. 333-199111) initially filed with the Securities and Exchange Commission (the “SEC”) on October 1, 2014, as amended from time to time (the “Registration Statement”), and is incorporated herein by reference. Any form of prospectus subsequently filed by the Registrant with the SEC pursuant to Rule 424(b) under the Securities Act of 1933, as amended, that constitutes part of the Registration Statement shall be deemed to be incorporated herein by reference.
Item 2. Exhibits.
Pursuant to the Instructions as to Exhibits with respect to Form 8-A, the Registrant is not required to file any exhibits because no other securities for the Registrant are registered on an exchange and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
|
|
S1 BIOPHARMA, INC. | |
|
|
| |
|
|
| |
|
Date: November 26, 2014 |
By: |
|
|
|
|
|
|
|
|
President and Chief Financial Officer |
| This ‘8-A12B/A’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed as of: | 11/26/14 | |||
| Filed on: | 11/25/14 | |||
| 10/1/14 | S-1 | |||
| List all Filings | ||||